Podcast Episode

From expanded OTC access in some states to persistent online claims, ivermectin is once again popping up in patient conversations—and bringing plenty of confusion with it.

In this episode, Don and Steve dig into what’s driving the buzz and what the evidence actually shows across a surprisingly wide range of uses. From viral misinformation to emerging global health research, they explore where ivermectin fits… and where it doesn’t.

Along the way, they tackle one of the biggest challenges in practice: how to respond when patients ask about therapies fueled more by headlines than high-quality data—and how to keep those conversations grounded, practical, and patient-centered. Plus, they feature insights from an oncology specialist on real-world patient scenarios.

🦠 Is ivermectin still being used for COVID-19—and what does the latest evidence really show?
🧬 How should healthcare professionals respond to patients asking about ivermectin for cancer?
💊 When might oral ivermectin make sense for certain conditions, like rosacea?
🌍 Could ivermectin help reduce malaria transmission—and why does context matter?

Let’s worm through the data and track down what holds up—and what doesn’t.

They put these claims under the microscope:

Ivermectin prevents and cures COVID-19.
Ivermectin prevents and cures cancer.
Oral ivermectin may improve rosacea.
Ivermectin can reduce malaria transmission.

🏷️ Our listeners can get 10% off a new or upgraded subscription with code rvt1026 at checkout.

******

TRC Healthcare Editor Hosts:

Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC
Don Weinberger, PharmD, PMSP

******

Guest:

Leslie Gingo, PharmD, BCPS

******

CE Information:

None of the speakers have anything to disclose.

TRC Healthcare offers CE credit for this podcast for subscribers at our platinum level or higher. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: